Commercial
MPIssuedDate
  
MPNewsFlashTopicPub
MPNFSortOrder
  
MPPolicyPageName
  
MPPurposePub
Title
  
MPPageName
  
11/25/2020
​Notice of Withdrawal of Advance Notification of Future Policy #00.10.41h: Telemedicine Services​ (AmeriHealth Pennsylvania)
0
The purpose of this communication is to provide notice that Advance Notification of future Policy​ #00.10.41h: Telemedicine Services (AmeriHealth Pennsylvania)​ has been withdrawn from the Medical Policy Portal.​
Notice of Withdrawal of Advance Notification of Future Policy #00.10.41h: Telemedicine Services488be3d7-9066-4c5c-9823-d18ec61c663e
11/25/2020
Veklury® (remdesivir) and Bamlanivimab® (LY-CoV555) for COVID-19 Treatment for AmeriHealth Pennsylvania Commercial Members
0


To Communicate the Company's coverage position for Veklury® (remdesivir) and Bamlanivimab® (LY-CoV555) for COVID-19 treatment for the Company's AmeriHealth Pennsylvania Commercial products.  ​


This communication addressing Treatments for SARS-CoV-2 (Coronavirus Disease 2019 (COVID-19)) is effective from October 22, 2020 through March 31, 2021, or the duration of the public health emergency. ​​


Veklury® (remdesivir) and Bamlanivimab® (LY-CoV555) for COVID-19 Treatment for AmeriHealth Pennsylvania Commercial Members05be5a68-72c3-47f5-bbea-832b971a9d25
11/25/2020
Veklury® (remdesivir) and Bamlanivimab® (LY-CoV555) for COVID-19 Treatment for AmeriHealth New Jersey Commercial Members
0


To Communicate the Company's coverage position for Veklury® (remdesivir) and Bamlanivimab® (LY-CoV555) for COVID-19 treatment for the Company's AmeriHealth New Jersey​ Commercial products.  ​


This communication addressing Treatments for SARS-CoV-2 (Coronavirus Disease 2019 (COVID-19)) is effective from October 22, 2020 through March 31, 2021 through the duration of the state of emergency and public health emergency as described in Executive Order 103.​


Veklury® (remdesivir) and Bamlanivimab® (LY-CoV555) for COVID-19 Treatment for AmeriHealth New Jersey Commercial Members104fa151-5b29-4c62-bdd7-030e9ca1edfc
10/6/2020
Testing for SARS-CoV-2 (Coronavirus Disease 2019 (COVID-19)) for AmeriHealth New Jersey Members
1
The purpose of this News Article is to provide advance notice regarding information and procedure and diagnosis codes related to testing for SARS-CoV-2 (Coronavirus Disease 2019 (COVID-19)) for AmeriHealth New Jersey members.

Testing for SARS-CoV-2 (Coronavirus Disease 2019 (COVID-19)) for AmeriHealth New Jersey Members87c36a80-9df9-4040-b8c3-a7b52a0f4c4b
10/6/2020
Testing for SARS-CoV-2 (Coronavirus Disease 2019 (COVID-19)) For AmeriHealth Pennsylvania Members
1
The purpose of this News Article is to provide advance notice regarding information and procedure and diagnosis codes related to testing for SARS-CoV-2 (Coronavirus Disease 2019 (COVID-19)) for AmeriHealth Pennsylvania members.​​
Testing for SARS-CoV-2 (Coronavirus Disease 2019 (COVID-19)) For AmeriHealth Pennsylvania Members4f170b20-b76e-4053-b3ea-f906eb3e914c
10/1/2020
10/1/2020 CPT & HCPCS Quarterly Code Update Coverage Determinations for Commercial Products
1
The intent of this article is to communicate Commercial Product coverage determinations for services identified through the Quarterly Code Update process. The procedure codes that represent these services will become effective on 10/1/2020, unless otherwise noted.

For more information related to these services, please refer to specific policies when applicable.​

10/1/2020 CPT & HCPCS Quarterly Code Update Coverage Determinations for Commercial Productsc1c57826-12dd-47cc-b303-2102ee13691a
7/17/2020
​Respiratory Equipment and Related Supplies (updated July 17, 2020)
1
The purpose of this News Article is to provide advance notice during the COVID-19 outbreak related to respiratory equipment and related supplies.
Respiratory Equipment and Related Supplies (updated July 17, 2020)5B5700A06FC104F9852585A70077812F
7/17/2020
Consumer Grade Pulse Oximetry Devices For Use In The Home Setting
1
The purpose of this News Article is to provide advance notice during the COVID-19 outbreak related to the coverage of consumer grade pulse oximetry devices for use in the home setting.
Consumer Grade Pulse Oximetry Devices For Use In The Home Setting2303C257FD64D4E4852585A700799D42
7/17/2020
Coverage of Vaxelis, diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed, inactivated poliovirus, Hemophilus b conjugate and Hepatitis B vaccine
1
The purpose of this NewsFLASH is to provide notice regarding updated coverage information for diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed, inactivated poliovirus, Hemophilus b conjugate and Hepatitis B vaccine for individuals enrolled in the Company's Commercial Products.
Coverage of Vaxelis, diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed, inactivated poliovirus, Hemophilus b conjugate and Hepatitis B vaccine44178692A23418F5852585A8006D7D18
7/1/2020
7/1/2020 CPT & HCPCS Quarterly Code Update Coverage Determinations for Commercial Products
1
7/1/2020 CPT & HCPCS Quarterly Code Update Coverage Determinations for Commercial Products5D38243F686BE26685258598006308EB
1 - 10Next